As the Meeting will be in a virtual-only format, registered and non-registered securityholders will not be able to attend in person. CRH strongly encourages all registered Shareholders, optionholders and share unit holders who would like to attend, participate and/or vote
virtually online via live webcast to carefully follow the procedures outlined in the Circular, which is available on the SECs website at http://www.sec.gov, on SEDAR at www.sedar.com and on the Companys website at
http://investors.crhsystem.com. If you are a non-registered Shareholder, you will be able to attend, participate and/or vote at the Meeting online via live webcast only if you duly appoint yourself as
proxyholder through the method specified by your intermediary. If a non-registered Shareholder does not comply with these requirements, you will be able to attend the Meeting online via live webcast as a guest
but will not be able to vote or ask questions.
At the Meeting, CRH securityholders will be asked to consider and, if thought advisable,
to pass a special resolution approving the Arrangement, as well as a proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to CRHs named executive
officers in connection with the Arrangement. The Circular contains a detailed description of the Arrangement, as well as certain additional information relating to CRH. If the requisite securityholder approval is obtained at the Meeting and if the
other conditions to the Arrangement becoming effective are satisfied or waived, it is expected that the Arrangement will be completed in the second quarter of 2021.
YOUR VOTE IS IMPORTANT - PLEASE VOTE TODAY
SHAREHOLDER QUESTIONS AND ASSISTANCE
If
you have any questions or require assistance voting your CRH securities, please contact our proxy solicitation agent, Laurel Hill Advisory Group, at
1-877-452-7184 toll-free in North America, or outside North America at 1-416-304-0211, or by e-mail at assistance@laurelhill.com.
Cautionary Note Regarding Forward-Looking Statements
Certain statements and information included or incorporated by reference in this document may constitute forward-looking statements
within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and forward-looking information within the meaning of Canadian securities laws (collectively, forward-looking statements). Forward looking
statements include statements regarding the acquisition of the Company by WELL Health and the expected timetable for completing such proposed transaction, as well as all other statements that are not statements of historical fact. Forward-looking
statements are generally identifiable by use of the words may, will, should, expect, anticipate, estimate, believe, plan, intend or
project or the negative of these words or other variations on these words or comparable terminology.
Forward-looking
statements reflect current expectations of management regarding future events and performance as of the date of this document and involve known and unknown risks, uncertainties and other factors which may cause our actual results to be materially
different those expressed or implied by any forward-looking statements. These forward-looking statements should not be read as guarantees of future results, and there can be no assurance that the results expressed or implied by any forward-looking
statements will be achieved. Important factors that could cause actual results to differ materially from the results discussed in forward-looking statements include: (i) the risk that the Companys securityholders do not approve the
proposed transaction; (ii) the risk that regulatory or other approvals required for the transaction may be delayed or not obtained, or are obtained subject to conditions that are not anticipated; (iii) the possibility that certain other
conditions to the consummation of the proposed transaction will not be satisfied or completed on a timely basis, or at all; (iv) the risk that the financing necessary for the consummation of the proposed transaction is unavailable at the
closing; (v) the risk of disruption from the announcement, pendency and/or completion of the potential transaction, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators,
making it more difficult to maintain business and operational relationships; (vi) uncertainties related to developments in the COVID-19 pandemic and its impact on the Companys operations and the
completion of the proposed transaction; and (vii) uncertainties related to general economic, financial, regulatory and political conditions, as well as potential changes in law and regulatory interpretations.
Additional factors that could cause actual results to differ materially from expectations include, without limitation, the risks identified by
the Company in its most recent Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q and its Current Reports on Form
8-K, which are available on EDGAR at www.sec.gov/edgar.shtml or on the Companys website at www.crhmedcorp.com. The Company disclaims any intent or obligations to update or revise publicly any
forward-looking statements whether as a result of new information, estimates or options, future events or results or otherwise, unless required to do so by law.
2